|
JPH1050306A
(ja)
*
|
1996-07-31 |
1998-02-20 |
Toyota Autom Loom Works Ltd |
水素吸蔵合金電極の製造方法
|
|
BE1011045A3
(fr)
*
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
|
US20050085498A1
(en)
*
|
1998-05-28 |
2005-04-21 |
Byrd Edward A. |
Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
|
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
|
JP2001107258A
(ja)
*
|
1999-10-06 |
2001-04-17 |
Hitachi Ltd |
無電解銅めっき方法とめっき装置および多層配線基板
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
AU764453B2
(en)
*
|
1999-10-29 |
2003-08-21 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
EP1118321A1
(fr)
*
|
2000-01-14 |
2001-07-25 |
Ucb, S.A. |
Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
|
|
US6242003B1
(en)
|
2000-04-13 |
2001-06-05 |
Novartis Ag |
Organic compounds
|
|
GB0009522D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Smithkline Beecham Plc |
Composition
|
|
MXPA03003895A
(es)
|
2000-10-30 |
2003-07-28 |
Euro Celtique Sa |
Formulaciones de hidrocodona de liberacion controlada.
|
|
US20060127474A1
(en)
|
2001-04-11 |
2006-06-15 |
Oskar Kalb |
Pharmaceutical compositions comprising fluvastatin
|
|
DE60232445D1
(de)
|
2001-06-28 |
2009-07-09 |
Ucb Farchim Sa |
Cetirizin und pseudoephedrin enthaltende tablette
|
|
CA2451519C
(en)
*
|
2001-06-28 |
2007-11-06 |
Ucb, Farchim, S.A. |
Tablet comprising cetirizine and pseudoephedrine
|
|
US20030092724A1
(en)
*
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
ES2285088T3
(es)
*
|
2002-01-09 |
2007-11-16 |
Ucb Farchim S.A. |
Composiciones farmaceuticas de liberacion modificada.
|
|
WO2003084511A1
(en)
*
|
2002-04-04 |
2003-10-16 |
Pfizer Products Inc. |
Palatable chewable tablet
|
|
EP1545468A4
(en)
*
|
2002-09-20 |
2007-06-20 |
Alpharma Inc |
SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
|
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
|
DE60322577D1
(de)
*
|
2002-12-06 |
2008-09-11 |
Ucb Farchim Sa |
Tablette enthaltend efletirizin und pseudoephedrin
|
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
|
US20060029664A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing carbetapentane and another drug
|
|
US20050281875A1
(en)
*
|
2003-12-17 |
2005-12-22 |
Sovereign Pharmaceuticals, Ltd. |
Promethazine containing dosage form
|
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US20050232986A1
(en)
*
|
2003-12-17 |
2005-10-20 |
David Brown |
Dosage form containing promethazine and another drug
|
|
US9492541B2
(en)
*
|
2004-09-14 |
2016-11-15 |
Sovereign Pharmaceuticals, Llc |
Phenylepherine containing dosage form
|
|
US20050232987A1
(en)
*
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
|
US7897172B2
(en)
*
|
2004-05-18 |
2011-03-01 |
L. Perrigo Company |
Tablets exhibiting reduced drug release variability
|
|
US9308164B2
(en)
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
|
US20070003622A1
(en)
*
|
2004-12-16 |
2007-01-04 |
Sovereign Pharmaceuticals, Ltd. |
Diphenhydramine containing dosage form
|
|
US9592197B2
(en)
*
|
2004-12-16 |
2017-03-14 |
Sovereign Pharmaceuticals, Llc |
Dosage form containing diphenhydramine and another drug
|
|
WO2006022996A2
(en)
*
|
2004-08-04 |
2006-03-02 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US7529255B2
(en)
*
|
2005-04-21 |
2009-05-05 |
Microsoft Corporation |
Peer-to-peer multicasting using multiple transport protocols
|
|
KR20080030546A
(ko)
*
|
2005-07-26 |
2008-04-04 |
유씨비 파마, 에스.에이. |
레베티라세탐을 포함하는 약제 조성물 및 이의 제조 방법
|
|
DK1940467T3
(da)
|
2005-09-09 |
2017-02-13 |
Paladin Labs Inc |
Lægemiddelsammensætning med langvarig frigivelse
|
|
CN101252932B
(zh)
*
|
2005-09-09 |
2012-10-03 |
安吉利尼莱博法姆有限责任公司 |
用于一天给药一次的曲唑酮组合物
|
|
EP1991207A2
(en)
*
|
2006-01-21 |
2008-11-19 |
Abbott GmbH & Co. KG |
Dosage form and method for the delivery of drugs of abuse
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
KR100753480B1
(ko)
*
|
2006-01-27 |
2007-08-31 |
씨제이 주식회사 |
잘토프로펜 함유 서방성 정제 및 그 제조방법
|
|
US20070253927A1
(en)
*
|
2006-04-13 |
2007-11-01 |
Gwenaelle Jegou |
Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
|
|
WO2007141743A2
(en)
*
|
2006-06-06 |
2007-12-13 |
Ranbaxy Laboratories Limited |
A tablet dosage form comprising cetirizine and pseudoephedrine
|
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
|
MX2008016349A
(es)
*
|
2006-06-19 |
2009-01-28 |
Accu Break Technologies Inc |
Formas segmentadas de dosificacion farmaceutica.
|
|
US8765178B2
(en)
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
|
JP5597394B2
(ja)
|
2006-09-25 |
2014-10-01 |
コーニンクレッカ フィリップス エヌ ヴェ |
回転ｘ線撮像における完全軌道に対する対象物の移動
|
|
EP2124556B1
(en)
|
2006-10-09 |
2014-09-03 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
JP2010510320A
(ja)
|
2006-11-21 |
2010-04-02 |
マクニール−ピーピーシー・インコーポレーテツド |
改変型放出鎮痛性懸濁液
|
|
US9833510B2
(en)
*
|
2007-06-12 |
2017-12-05 |
Johnson & Johnson Consumer Inc. |
Modified release solid or semi-solid dosage forms
|
|
KR20100069685A
(ko)
*
|
2007-10-16 |
2010-06-24 |
라보팜 인코포레이트 |
아세트아미노펜과 트라마돌의 지속 방출을 위한 이중층 조성물
|
|
EP2217279B1
(en)
*
|
2007-11-21 |
2017-11-01 |
The Procter & Gamble Company |
Preparations useful for treatment of cough
|
|
US8486448B2
(en)
|
2007-12-17 |
2013-07-16 |
Paladin Labs Inc. |
Misuse preventative, controlled release formulation
|
|
ES2620672T3
(es)
|
2008-01-09 |
2017-06-29 |
Charleston Laboratories, Inc. |
Comprimidos de doble capa que comprenden oxicodona y prometazina
|
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
|
AU2009327312A1
(en)
|
2008-12-16 |
2011-08-04 |
Labopharm Europe Limited |
Misuse preventative, controlled release formulation
|
|
WO2010078486A2
(en)
|
2008-12-31 |
2010-07-08 |
Upsher-Smith Laboratories, Inc. |
Opioid-containing oral pharmaceutical compositions and methods
|
|
WO2011006012A1
(en)
|
2009-07-08 |
2011-01-13 |
Charleston Laboratories Inc. |
Pharmaceutical compositions
|
|
CA2773521C
(en)
|
2009-09-17 |
2017-01-24 |
Upsher-Smith Laboratories, Inc. |
A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
|
|
CA2798702A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholresistant metoprolol-containing extended-release oral dosage forms
|
|
CN102302497A
(zh)
*
|
2011-05-18 |
2012-01-04 |
天圣制药集团股份有限公司 |
一种治疗过敏性鼻炎的制剂及其制备方法
|
|
CA2899492C
(en)
|
2013-02-13 |
2019-09-17 |
The Procter & Gamble Company |
Anise flavored medication
|
|
KR102070076B1
(ko)
*
|
2013-05-03 |
2020-01-29 |
주식회사 제닉 |
탄산 함유 입자를 포함하는 필름
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
SG11201607511WA
(en)
|
2014-03-11 |
2016-10-28 |
Redhill Biopharma Ltd |
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
|
|
JP2019507181A
(ja)
|
2016-03-04 |
2019-03-14 |
チャールストン ラボラトリーズ，インコーポレイテッド |
医薬組成物
|
|
RU2687715C1
(ru)
*
|
2018-05-07 |
2019-05-15 |
Федеральное государственное бюджетное учреждение науки Институт горного дела Дальневосточного отделения Российской академии наук |
Способ комбинированной разработки россыпных месторождений золота
|
|
US12589083B2
(en)
|
2019-05-07 |
2026-03-31 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
US11324707B2
(en)
|
2019-05-07 |
2022-05-10 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
|
KR102073185B1
(ko)
*
|
2019-07-16 |
2020-02-04 |
(주)위바이오트리 |
활성성분을 포함하는 변성 다중층 수산화물 구조체를 포함하는 금속 수산화물 복합체 및 이의 제조 방법
|